Literature DB >> 26547888

Perianal pyoderma gangrenosum after excision and fulguration of anal condyloma acuminatum.

Jennifer L Agnew1, Paul D Strombom2, Carmen F Fong3, Timothy J Kelly4, Joseph E Martz5.   

Abstract

INTRODUCTION: Pyoderma gangrenosum (PG) is a rare, inflammatory skin pathology frequently associated with systemic inflammatory disease. While rare after surgery, recognition of this disease in the post-surgical setting is important as it can mimic wound infection. PRESENTATION OF CASE: We herein present a dramatic presentation of perianal PG four days after routine excision and fulguration of anal condyloma acuminatum. The affected area did not improve with broad spectrum antibiotics or surgical debridement. A diagnosis of PG was made from clinical suspicion and pathology findings, and further confirmed with rapid improvement after starting steroids. Diagnosis of this disease in the postoperative period requires high suspicion when the characteristic ulcerative or bullae lesions are seen diffusely and show minimal improvement with antibiotic treatment or debridement. DISCUSSION: Our case highlights the importance of recognizing this disease in the post-operative period, to allow for early initiation of appropriate treatment and prevent unnecessary surgical debridement of a highly sensitive area. There have been 32 case reports of PG in the colorectal literature, mostly following stoma creation. There is one case report of idiopathic perianal pyoderma gangrenosum with no known prior trauma. To our knowledge there are no previously reported cases of perianal PG after routine elective anorectal surgery.
CONCLUSION: This is the first reported case of perianal pyoderma gangrenosum in the post-surgical setting. Increased awareness of pyoderma gangrenosum in the surgical literature will aid in prompt diagnosis and proper medical management of this uncommon postoperative morbidity.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Anorectal surgery; Postoperative wound; Pyoderma gangrenosum

Year:  2015        PMID: 26547888      PMCID: PMC4701749          DOI: 10.1016/j.ijscr.2015.10.010

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

Pyoderma gangrenosum (PG) is a rare inflammatory dermatologic condition leading to skin ulceration, pustules or bullae. PG has a reported incidence of 3–10 million cases per year, with nearly half of the cases associated with an underlying systemic disease, such as inflammatory bowel disease, hematologic conditions and autoimmune disorders [1]. Though the etiology and pathogenesis is not well understood, the most accepted theory involves immunologic pathways and improperly functioning neutrophils. This hypothesis is supported by the clinical improvement of the condition with corticosteroids and immunosuppressive therapies [1]. Major and minor trauma is also believed to play a role, and has led to recognition of cases of postsurgical pyoderma gangrenosum (PSPG) [2]. Within the colorectal literature, the majority of cases are noted in patients with underlying inflammatory bowel disease (IBD) undergoing abdominal surgical procedures. Here we describe the first reported case of perianal PSPG after an anorectal surgical procedure.

Presentation of case

A 41-year-old Caucasian male who has sex with men presented to colorectal surgery for outpatient evaluation of anal warts. The patient reported a history of anal herpes simplex virus treated with oral valcyclovir, as well as anal warts treated with exam under anesthesia at an outside hospital 1.5 years prior to current presentation. During preoperative evaluation for his prior procedure, the patient was noted to be anemic and was diagnosed with myelodysplastic syndrome for which he completed a course of oral prednisone. The patient now reported recurrent anal warts associated with pain, itching and discomfort. Clinical exam revealed several wart-like growths in the anal canal. The patient underwent an uneventful ambulatory examination under anesthesia with excision and fulguration of the anal canal lesions. Final surgical pathology reported condyloma acuminatum. Four days after the ambulatory procedure, the patient returned to the office complaining of severe right-sided perianal pain radiating to the groin, with subjective fever and chills. On exam, the patient was afebrile, with low-grade tachycardia but normotensive. His abdomen was soft and without tenderness or distension. The perianal area showed moderate edema and minimal erythema with tenderness to palpation, but without fluctuance, purulence or crepitus. Laboratory studies revealed a leukocytosis of 15,000 cell/mcL (92% neutrophils). Computed tomography (CT) of the pelvis ruled out deep abscess or collection, but was remarkable for mild inflammation of the perianal skin and tissue surrounding the rectum (Fig. 1). The patient was admitted to the hospital for pain control and antibiotic therapy (ciprofloxacin and metronidazole). Clinical impression at that time was concerning for an infectious process with associated postoperative inflammatory reaction or altered immune response secondary to the patient's underlying comorbidity of myelodysplastic syndrome.
Fig. 1

Initial computed tomography of the pelvis revealing mild inflammation of the perianal skin and tissue surrounding the rectum.

Over the following three days, the patient was observed in the hospital wards while on intravenous antibiotics. While his perianal clinical exam did not change, the patient began to experience febrile episodes as high at 104 °F (40 °C) and his leukocytosis persisted. By the fourth hospital day, on clinical exam the patient had developed significant bilateral perianal ecchymoses and perianal edema with increased tenderness to palpation (Fig. 2A). CT of the pelvis was repeated and only remarkable for increased circumferential perianal inflammation and edema without any appreciable underlying abscess (Fig. 2B). Given the worsening clinical exam findings, the patient was consented and taken to the operating room for exam under anesthesia and debridement. In the operating room he was found to have severe perianal inflammation and induration, proctitis, and desquamation of the perianal skin and anal canal. Only superficial epidermal debridement was necessary to encounter viable tissue (Fig. 3). Tissue biopsies were taken and cultures were sent. An infectious disease consultation was obtained and the antibiotic regimen was broadened to cefepime, doxycycline, metronidazole, and vancomycin in order to cover methicillin-resistant staphylococcus aureus, streptococcus, enterococcus, gonorrhea, and Chlamydia. Valcyclovir was also added to cover herpes simplex virus.
Fig. 2

(A) Initial clinical manifestation consisting of bilateral perianal ecchymoses and perianal edema, which developed on postoperative day 7; (B) computed tomography of the pelvis repeated on postoperative day 7 revealing increased circumferential perianal inflammation and edema without abscess formation.

Fig. 3

Intraoperative photograph after superficial debridement and tissue biopsy.

Over the following two postoperative days, his clinical exam again worsened with development of ecchymoses and bullae formation where he had previously been debrided (Fig. 4). Given the poor response to antibiotics and debridement, a dermatology consult was obtained with concern for an underlying autoimmune inflammatory process. Dermatological assessment was clinically most consistent with pyoderma gangrenosum. Clinical signs of pathergy were noted, including the worsening of the clinical exam after further trauma to the area after debridement. Intravenous methylprednisolone 125 mg daily was initiated.
Fig. 4

Early development of ecchymoses and bullae formation on postoperative day one and two after debridement and biopsy.

Surgical pathology of the tissue biopsies revealed denuded epidermis with ulcer bed and diffuse, exudative infiltrate of neutrophils extending into subcutaneous fat, with fibrin thrombi, suppurative folliculitis and neutrophilic eccrine hidradenitis. The histopathological findings were all suggestive of a diffuse necrotizing neutrophilic dermopathy such as pyoderma gangrenosum. Intraoperative viral cultures were negative, however, bacterial cultures grew vancomycin-resistant enterococcus, which was thought to be more likely a colonized bacteria and less likely a pathogen. All antibiotic therapy was discontinued after a five-day course of linezolid was completed as per infectious disease consultation recommendation. The patient was continued on intravenous steroids with significant improvement of perianal skin on clinical exam. He remained afebrile, his white blood cell count normalized, and the bullae formation and inflammatory process regressed (Fig. 5). Cautious local wound care was implemented and consisted of non-adherent dressings to cause minimal trauma to the area. The patient was transitioned to oral steroids and discharged from the hospital. The patient will undergo an outpatient steroid taper and be managed with cyclosporine per dermatology.
Fig. 5

Significant clinical improvement of affected area after 4 days (A) and 11 days (B) of intravenous steroid therapy.

Discussion

Pyoderma gangrenosum is an uncommon neutrophilic dermatosis which presents as extensive skin ulceration and has often been missed or misdiagnosed. Clinically it can be mistaken as necrotizing fasciitis, hidradenitis suppurativa, or herpes infection. Pathologically, both PG and necrotizing fasciitis can be characterized by sterile infiltration of the skin by neutrophils with additional, non-specific features of vasculitis, necrosis, edema and abscess formation [3]. While the treatment for necrotizing fasciitis and hidradenitis includes antibiotics and aggressive surgical debridement, PG is unresponsive to antibiotic therapy and surgical intervention usually worsens the clinical manifestations of PG [4]. Typically, a diagnosis of PG is made on clinical suspicion and is often a diagnosis of exclusion after other etiologies such as infection and drug-reaction have been ruled out. The appropriate treatment is medical management, typically intravenous corticosteroids, although there have been recent discussions regarding immunosuppressive therapy or monoclonal antibody therapy [1]. There have been several reports of PG occurring after surgical procedures in recent literature. Systematic review of the literature reveals that PSPG most commonly occurs after breast surgery [5], though reports also exist after cardiothoracic [6], abdominal [7], orthopedic [8], and obstetric [9] procedures. Typically, PSPG presents within 1 week of surgery, though reports of later presentations exist. Patients at risk for developing PSPG included those with underlying comorbidities, such as hematologic disorders including leukemia or lymphoma (8.6%), inflammatory bowel disease (5.9%), and rheumatoid arthritis (3.6%) [2]. Outcomes vary after presentation of PSPG. Many patients recover well after correct diagnosis and initiation of immunosuppressive therapies. Common sequelae include extended recovery period and poor cosmetic outcomes [2]. However, more severe complications including death have been reported, particularly in cases of PSPG after cardiothoracic procedures [10]. In the colorectal literature, PG occurs most commonly after surgical stoma creation and has been recognized as early as 1984 ]11]. An analysis examining 32 cases suggested that PG can complicate as many as 0.6% of all stoma creations. PG occurred most commonly after ileostomy creation, and the vast majority of these cases occurred in patients with IBD. Unlike other reports of PSPG, PG complicating stoma creation can have a delayed presentation of up to 2 years [12]. Aside from parastomal PG, few reported cases of PSPG exist after operative surgical resection of rectal cancer in otherwise healthy patients without inflammatory bowel disease, presenting most commonly surrounding the abdominal incisions [13], [14]. There has been one case report of perianal pyoderma gangrenosum in the Spanish literature of a 71-year-old male without any significant surgical or medical history. The patient presented with extensive, painful perianal ulcers that were successfully treated with tacrolimus and oral prednisone [15]. This case was one of idiopathic pyoderma gangrenosum and was not provoked by trauma. To our knowledge, the case described here in this manuscript is the first reported case of postsurgical perianal pyoderma gangrenosum after an anorectal procedure for benign disease.

Conclusion

Pyoderma gangrenosum is a rare postoperative complication that can occur in response to the trauma of surgery, particularly in patients with underlying immunological and hematologic comorbidities. It is of clinical significance as it can mimic a surgical site infection and the condition may worsen if surgical debridement is attempted. Although a high index of suspicion for potential complications following anorectal surgery must include infectious and necrotizing fasciitis, the potential of secondary processes including PG must be entertained. To our knowledge this case presentation is the first reported occurrence of perianal pyoderma gangrenosum after an ambulatory anorectal surgical procedure. Increased awareness of pyoderma gangrenosum in the surgical literature will aid in prompt diagnosis and proper medical management of this uncommon postoperative morbidity.

Consent

Informed consent was obtained from the patient for publication of this case report and accompanying images.

Conflict of interest

The authors have no disclosures.
  15 in total

1.  Pyoderma gangrenosum with extensive perianal involvement.

Authors:  Marlén Alvite-Canosa; Inmaculada Monjero-Ares; Leticia Alonso-Fernández; Ana Alvarez-Gutiérrez; Rocío González-López; Olga Maseda-Díaz; Félix Arija-Val
Journal:  Rev Esp Enferm Dig       Date:  2012-02       Impact factor: 2.086

2.  Peristomal pyoderma gangrenosum associated with rectal adenocarcinoma.

Authors:  Horiyuki Sakai; Sawa Otsubo; Hajime Iizuka
Journal:  J Dermatol       Date:  2006-01       Impact factor: 4.005

Review 3.  Pyoderma gangrenosum following patellar tendon repair: a case report and review of the literature.

Authors:  Tony Wanich; Andrew N Swanson; Angela J Wyatt; Anne M Kelly
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2012-01

Review 4.  A systematic review of post-surgical pyoderma gangrenosum: identification of risk factors and proposed management strategy.

Authors:  Kevin J Zuo; Eric Fung; Edward E Tredget; Andrew N Lin
Journal:  J Plast Reconstr Aesthet Surg       Date:  2014-12-29       Impact factor: 2.740

5.  Pyoderma gangrenosum after cholecystectomy.

Authors:  A J Carr; R C Percival; K Rogers; C T Harrington
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

6.  Pyoderma gangrenosum at the parastomal site in patients with Crohn's disease.

Authors:  W C McGarity; D B Robertson; P P McKeown; J R Amerson; W A Darden
Journal:  Arch Surg       Date:  1984-10

Review 7.  Management of pyoderma gangrenosum.

Authors:  Alexandra Teagle; Rachel Hargest
Journal:  J R Soc Med       Date:  2014-06-09       Impact factor: 5.344

Review 8.  [Pyoderma gangrenosum following cesarean delivery].

Authors:  C Sanz-Muñoz; C Martínez-Morán; A Miranda-Romero
Journal:  Actas Dermosifiliogr       Date:  2008 Jul-Aug

9.  Untreatable surgical site infection: consider pyoderma gangrenosum.

Authors:  Ilan Berlinrut; Nitasha Bhatia; Jonathan M Josse; David de Vinck; Sanjeev Kaul
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-07-09

10.  Severe, Steroid-responsive, Myositis Mimicking Necrotizing Fasciitis following Orthopedic Surgery: A Pyoderma Variant with Myonecrosis.

Authors:  Alistair B Reid; Peter Stanley; Damien Grinsell; John R Daffy
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-07-09
View more
  2 in total

Review 1.  Systemic and Autoimmune Diseases.

Authors:  Xavier Delgadillo; Adrián E Ortega; Alejandro Moreira Greco
Journal:  Clin Colon Rectal Surg       Date:  2019-09-06

2.  Pyoderma gangrenosum faciale in a patient with Crohn's disease.

Authors:  Timothy Arleo; Justin Cheeley
Journal:  JAAD Case Rep       Date:  2020-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.